Equities

Volpara Health Technologies Ltd

Volpara Health Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)1.15
  • Today's Change0.00 / 0.00%
  • Shares traded1.35m
  • 1 Year change+54.73%
  • Beta2.0571
Data delayed at least 20 minutes, as of May 03 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.

  • Revenue in AUD (TTM)34.65m
  • Net income in AUD-8.14m
  • Incorporated2009
  • Employees156.00
  • Location
    Volpara Health Technologies LtdLevel 12, 86 Victoria StreetWELLINGTON 6011New ZealandNZL
  • Phone+64 44996029
  • Websitehttps://www.volparahealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dropsuite Ltd31.35m1.58m180.98m--116.596.6199.995.770.00220.00220.04410.03931.08--6.51--5.46-3.006.12-3.42----5.05-3.02--396.250.0052--49.6342.749.24---22.73--
Medadvisor Ltd109.43m-9.03m181.55m100.00--3.24--1.66-0.0166-0.01660.20060.1020.9056--4.68---7.47-24.51-13.47-36.7658.8959.77-8.25-26.98---3.040.1847--44.6067.6634.83---15.12--
Oneview Healthcare PLC15.35m-14.59m182.06m79.00--12.10--11.86-0.025-0.0250.02610.02230.54211.864.48194,307.90-51.54-63.80-114.41-130.5365.6061.07-95.08-128.721.51-16.940.0928--5.332.7617.80---6.93--
Ansarada Group Ltd53.34m-2.57m205.48m----4.5515.393.85-0.0288-0.02880.59560.50570.6818--9.01---3.29-8.53-5.02-12.0196.31---4.82-13.27---0.27140.1027--7.20138.1641.37------
Volpara Health Technologies Ltd34.65m-8.14m291.26m156.00--6.66--8.41-0.0322-0.03220.13680.17190.4595--3.08222,117.10-10.80-24.41-16.41-32.0092.2790.59-23.50-77.02---16.460.027--34.0765.5940.39--74.44--
TASK Group Holdings Limited67.98m1.82m292.19m--159.862.3421.854.300.00510.00510.19160.35070.4155--6.42--1.11-9.011.34-10.75----2.67-18.73---5.670.0429--99.4441.24101.50--22.80--
DUG Technology Ltd89.09m4.85m333.11m237.0070.408.2721.683.740.04010.04010.73160.3411.03--3.98--6.42-13.4410.14-21.13----6.21-15.29--5.950.4567--46.281.80154.40---16.46--
3P Learning Ltd109.37m-5.93m337.73m243.00--1.8295.653.09-0.0216-0.02160.39620.67620.4197--8.88---2.290.3551-3.030.4979-----5.450.76370.5321-96.060.01270.0010.0914.101,288.43---16.52--
Playside Studios Ltd58.14m7.48m354.99m--48.527.3327.256.110.01790.01790.14140.11881.06--8.46--13.63-7.5816.54-9.18----12.87-8.76----0.0474--31.4749.65-243.71--85.05--
Catapult Group International Ltd140.70m-26.17m383.83m----2.9945.702.73-0.1078-0.10780.57950.49140.563911.513.84---10.51---16.82--80.17---18.63--0.5667-32.230.1327--9.54--1.96------
Readytech Holdings Ltd110.15m6.32m393.68m1.00k60.202.8116.903.570.0550.0550.9551.180.438--8.23--2.512.733.173.6791.6293.025.746.05--4.440.25860.0031.9632.16-43.43--41.61--
Data as of May 03 2024. Currency figures normalised to Volpara Health Technologies Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

20.16%Per cent of shares held by top holders
HolderShares% Held
Harbour Asset Management Ltd.as of 30 Apr 202438.56m15.16%
Norges Bank Investment Managementas of 31 Dec 20237.22m2.84%
Wellington Management Co. LLPas of 31 Jan 20242.94m1.16%
Jackson National Asset Management LLCas of 31 Dec 20231.74m0.68%
Dimensional Fund Advisors LPas of 04 Apr 2024231.75k0.09%
Bellatrix Asset Management SAas of 28 Mar 2024180.00k0.07%
DFA Australia Ltd.as of 31 Mar 2024150.41k0.06%
Baillie Gifford & Co.as of 29 Dec 2023144.42k0.06%
Serafin Asset Management AGas of 31 Dec 2023100.00k0.04%
Dimensional Fund Advisors Ltd.as of 04 Apr 202422.70k0.01%
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.